|

Asthma Clinical Trials in California

28 recruiting studies across 7 cities

Browse by City

Long Beach
20 trials
Los Angeles
20 trials
San Francisco
13 trials
San Jose
13 trials
San Diego
6 trials
Fresno
2 trials
Sacramento
2 trials

All Trials in California

Phase
Trial Phase Dist.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 3<1 mi
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in AdultsPhase 2<1 mi
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental DisabilitiesN/A<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
Mechanistic Insights From Bronchoscopy Airway Samples—<1 mi
Reducing Overuse of Antibiotics With Decision SupportN/A<1 mi
A Study of CDX-622 in Participants With Mild to Moderate AsthmaPhase 1<1 mi
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)Phase 4<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3<1 mi
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With AsthmaPhase 2<1 mi
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaPhase 2<1 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 2<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 2<1 mi
Mechanism(s) of Airflow Limitation During Exacerbation of AsthmaPhase 47 mi
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma—7 mi
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap—7 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 39 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)Phase 39 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Phase 39 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 310 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaPhase 210 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 310 mi
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and EndotypingPhase 411 mi
Food Allergy Registry at a Single Site—16 mi
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 AsthmaPhase 319 mi
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice—21 mi
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects—45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.